ROS-mediated upregulation of Noxa overcomes chemoresistance in chronic lymphocytic leukemia.
about
Sensitization of ovarian cancer cells to cisplatin by gold nanoparticlesPhospho-specific flow cytometry identifies aberrant signaling in indolent B-cell lymphomaOrganometallic nucleosides induce non-classical leukemic cell death that is mitochondrial-ROS dependent and facilitated by TCL1-oncogene burden.Inhibition of Autophagy Potentiated the Antitumor Effect of Nedaplatin in Cisplatin-Resistant Nasopharyngeal Carcinoma CellsSynergistic inhibition of autophagy and neddylation pathways as a novel therapeutic approach for targeting liver cancer.ON 01910.Na is selectively cytotoxic for chronic lymphocytic leukemia cells through a dual mechanism of action involving PI3K/AKT inhibition and induction of oxidative stress.Dysfunction of the TP53 tumor suppressor gene in lymphoid malignancies.NOXA as critical mediator for drug combinations in polychemotherapy.Induction of TAp73 by platinum-based compounds to overcome drug resistance in p53 dysfunctional chronic lymphocytic leukemiaA review of the role of Puma, Noxa and Bim in the tumorigenesis, therapy and drug resistance of chronic lymphocytic leukemia.Noxa in rheumatic diseases: present understanding and future impact.Apoptosis inducers in chronic lymphocytic leukemia.Mcl-1 is vital for neutrophil survival.Noxa and cancer therapy: Tuning up the mitochondrial death machinery in response to chemotherapy.Efficacy of cisplatin-based immunochemotherapy plus alloSCT in high-risk chronic lymphocytic leukemia: final results of a prospective multicenter phase 2 HOVON study.Mild thermotolerance induced at 40 °C protects cells against hyperthermia-induced pro-apoptotic changes in Bcl-2 family proteins.The pan phosphoinositide 3-kinase/mammalian target of rapamycin inhibitor SAR245409 (voxtalisib/XL765) blocks survival, adhesion and proliferation of primary chronic lymphocytic leukemia cells.Oxidative stress and lipid peroxidation products in cancer progression and therapy.Platinum and high-dose cytarabine-based regimens are efficient in ultra high/high-risk chronic lymphocytic leukemia and Richter's syndrome: results of a French retrospective multicenter study.Noxa couples lysosomal membrane permeabilization and apoptosis during oxidative stress.CD40 stimulation sensitizes CLL cells to rituximab-induced cell death.Exploiting the pro-apoptotic function of NOXA as a therapeutic modality in cancer.Regulation of Chondrocyte Survival in Mouse Articular Cartilage by p63.NOXA contributes to the sensitivity of PERK-deficient cells to ER stress.
P2860
Q34227763-A7E5E0BE-4FC1-4DCA-9D52-4B2ADDC9E4CBQ34448586-4B435E74-94AB-405D-A57A-BEEC7FCFD6ADQ35676442-299A9B3D-C28E-4996-A7B9-2EE2B5B2564DQ35750358-8A2D2C1A-3F76-4FCD-91BF-2A34C660E87DQ35832285-BBD71CFC-6E63-451F-97EC-B0DD63FCDA23Q35875424-B58C759D-8341-43B4-8E68-D76A83030708Q35909637-5E3AFB1C-97A2-4832-AA33-F6251652C928Q36071973-371246ED-24FB-428A-832B-C9C27E318848Q36118111-94391C50-EAD5-4AB5-ABCF-8356503BD67CQ38061861-6053BC5B-97ED-4FE4-902B-F7CFCF0166DBQ38172397-3F9ACD24-D9A9-4EB1-86A3-25F4103A71FCQ38187815-3755AB8D-9352-4F0C-A7F0-B60485476C09Q38451839-2E7FBC54-7512-47B9-A7AB-1AD0B7DA5415Q38866647-18919CB8-6D24-4CE2-AA1B-187F7B54301AQ39996013-A1E39074-8129-49A7-ABFF-7A94521B982BQ40185074-ED7E2361-E5CD-4267-925E-CA79DB80BF66Q40575812-786712E0-7F29-4D58-815C-988DB2970608Q41646063-E4303FB7-2A0D-4FBC-8E02-9A6156E195A1Q41682806-E989B64F-1A99-4EB8-84AB-D599B498BF39Q41820954-A5125319-0698-4BDB-8BBC-926F6B60A9C6Q42485265-E2642959-733C-400E-96DE-F6F8935D5767Q50911306-44C31CE8-48BB-4CBA-816B-CA365F7A880DQ51356935-52EC1383-914F-4CF2-8A58-B933C17B0F4CQ54287535-FDF973FB-4D98-4F3C-9C76-52410A94D1E5
P2860
ROS-mediated upregulation of Noxa overcomes chemoresistance in chronic lymphocytic leukemia.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
ROS-mediated upregulation of N ...... chronic lymphocytic leukemia.
@en
type
label
ROS-mediated upregulation of N ...... chronic lymphocytic leukemia.
@en
prefLabel
ROS-mediated upregulation of N ...... chronic lymphocytic leukemia.
@en
P2093
P2860
P356
P1433
P1476
ROS-mediated upregulation of N ...... chronic lymphocytic leukemia.
@en
P2093
E Eldering
J van Laar
M H van Oers
S H Tonino
P2860
P2888
P304
P356
10.1038/ONC.2010.441
P407
P577
2010-10-11T00:00:00Z
P5875
P6179
1013948944